Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Allergan
Allergan
Sandoz to pay Allergan, Duke University $39M over eye drug lawsuit, jury says
Sandoz to pay Allergan, Duke University $39M over eye drug lawsuit, jury says
Endpoints
Sandoz
Allergan
Duke University
legal
patents
Latisse
Flag link:
Allergan’s DREAM initiative partners with Shutterstock to promote racial equity in aesthetics
Allergan’s DREAM initiative partners with Shutterstock to promote racial equity in aesthetics
Medical Marketing and Media
Allergan
aesthetics
racism
pharma marketing
DREAM initiative
Flag link:
Teva, AbbVie's Allergan lock in $6.6B deal to settle thousands of US opioid lawsuits
Teva, AbbVie's Allergan lock in $6.6B deal to settle thousands of US opioid lawsuits
Fierce Pharma
Teva Pharmaceutical
AbbVie
Allergan
opioids
legal
opioid crisis
Flag link:
AbbVie inks $54M settlement to resolve Namenda 'pay-for-delay' lawsuit
AbbVie inks $54M settlement to resolve Namenda 'pay-for-delay' lawsuit
Fierce Pharma
legal
AbbVie
Namenda
Alzheimer's disease
pay-for-delay
Allergan
Flag link:
AbbVie unveils 'See Yourself' Botox campaign, days after new rival approved
AbbVie unveils 'See Yourself' Botox campaign, days after new rival approved
Endpoints
AbbVie
Allergan
Botox
DTC ads
Daxxify
Revance Therapeutics
Flag link:
AbbVie fends off patent claim in unusual whistleblower case
AbbVie fends off patent claim in unusual whistleblower case
Fierce Pharma
AbbVie
whistleblower lawsuits
whistleblowers
Allergan
Adamas
Alzheimer's disease
Flag link:
Teva, AbbVie ink $58M opioid settlement to resolve San Francisco claims
Teva, AbbVie ink $58M opioid settlement to resolve San Francisco claims
Fierce Pharma
Teva Pharmaceutical
opioids
opioid crisis
San Francisco
legal
AbbVie
Allergan
Flag link:
AbbVie Inks Licensing Agreement To Use Sirona Biochem's New Skincare Technology
AbbVie Inks Licensing Agreement To Use Sirona Biochem's New Skincare Technology
CP WIre
Sirona Biochem
AbbVie
Allergan
aesthetics
TFC-1067
Flag link:
AbbVie Inks Licensing Agreement To Use Sirona Biochem's New Skincare Technology
Sirona Biochem
AbbVie
Allergan
aesthetics
TFC-1067
Flag link:
Teva, AbbVie's Allergan hand over $161M to settle opioid lawsuit in West Virginia
Teva, AbbVie's Allergan hand over $161M to settle opioid lawsuit in West Virginia
Fierce Pharma
AbbVie
Allergan
Teva Pharmaceutical
legal
opioids
opioid crisis
Flag link:
AbbVie, Teva looking to settle nationwide opioid litigation for $5B+: Bloomberg
AbbVie, Teva looking to settle nationwide opioid litigation for $5B+: Bloomberg
Fierce Pharma
AbbVie
Allergan
Teva Pharmaceutical
opioids
opioid crisis
legal
Flag link:
AbbVie's Q1 Good News That Investors Could Be Missing
AbbVie's Q1 Good News That Investors Could Be Missing
Motley Fool
AbbVie
Humira
earnings
Allergan
Flag link:
Rhode Island reaches $28.5-million in settlements with opioid manufacturers
Rhode Island reaches $28.5-million in settlements with opioid manufacturers
The Providence Journal, RI
opioids
opioid crisis
Rhode Island
Teva Pharmaceutical
Allergan
Flag link:
Teva, Endo and more back on the hook in San Francisco opioid trial
Teva, Endo and more back on the hook in San Francisco opioid trial
Fierce Pharma
opioids
San Francisco
Teva Pharmaceutical
Endo International
AbbVie
Allergan
Flag link:
AbbVie sees a megablockbuster in Vraylar. Could a new depression indication push peak sales past $4B?
AbbVie sees a megablockbuster in Vraylar. Could a new depression indication push peak sales past $4B?
Endpoints
AbbVie
Vraylar
Allergan
major depressive disorder
FDA
Flag link:
AbbVie notches reprieve in antitrust case involving blood pressure med snagged in $63B Allergan megamerger
AbbVie notches reprieve in antitrust case involving blood pressure med snagged in $63B Allergan megamerger
Fierce Pharma
AbbVie
antitrust
Bystolic
generics
Allergan
Flag link:
FDA restricts breast implant sales, cites Allergan and J&J for inadequate postapproval progress
FDA restricts breast implant sales, cites Allergan and J&J for inadequate postapproval progress
Medtech Dive
FDA
breast implants
devices
JNJ
Allergan
Medtech
Flag link:
AbbVie closes in on Biohaven with new migraine prevention OK for oral CGRP drug
AbbVie closes in on Biohaven with new migraine prevention OK for oral CGRP drug
Endpoints
AbbVie
Qulipta
migraines
Allergan
Biohaven
FDA
Flag link:
AbbVie hands back headline drug in $63B Allergan buyout to Molecular Partners after FDA rejection. What's next?
AbbVie hands back headline drug in $63B Allergan buyout to Molecular Partners after FDA rejection. What's next?
Endpoints
AbbVie
Allergan
Molecular Partners
Flag link:
Drugs facing the most patent expirations this year
Drugs facing the most patent expirations this year
Drug Patent Watch
patents
Novartis
Sunovion
Allergan
Bayer
Gilead Sciences
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »